# Pfizer - Financial Performance

**Generated:** 2025-12-09 00:10

*Revenue, profitability, and financial metrics*

---

## Financial Performance

### Annual Revenue and Growth
- **2024 Revenue**: $63.6 billion (7% year-over-year operational growth)
- **2023 Revenue**: $59.553 billion (41.14% decline from 2022)
- **Revenue Trend**: Pfizer annual revenue for 2024 was $63.627B, representing a 6.84% increase from 2023

### Quarterly Results
- **Q4 2024 Revenue**: $17.8 billion, an increase of $3.2 billion or 22% compared to the prior-year quarter

### Profitability Metrics
- **Earnings Per Share (TTM)**: $1.72
- **Revenue (TTM)**: $62.78B

### Key Financial Ratios
- **P/E Ratio (TTM)**: 15.13
- **Forward P/E**: 8.67
- **PEG Ratio**: 3.77
- **Price/Book**: 1.59

### Revenue by Segment
Specific segment breakdown data not available in current sources.

---

*This is part of the Pfizer research report. See [Full Report](00_full_report.md) for complete analysis.*
